Distribution of Various Mycotoxins in Compound Feed, Total Mix Ration and Silage

Present study was planned to assess the spectrum of natural occurrence of aflatoxins, zearalenone, ochratoxin A and A-B trichothecenes in dairy feed, silage and total mixed rations. One hundred and seventy one samples were analyzed by chromatographic technique. In cattle compound feed, there was a high incidence of aflatoxin B1 (97.3%) followed by aflatoxin B2 (50.3%), aflatoxin G1 (10.7%), aflatoxin G2 (1.5%), zearalenone (39.3%), ochratoxin A (37.5%) and deoxynivalenol (2.9%) with average values of 29, 8, 21, 10, 862, 64 and 813 ng/g respectively. Nine samples were found tainted with T-2 toxin (282ng/g), nivalenol (285ng/g) and fusarenon-x (1625ng/g) respectively. However, frequency distribution showed that positive seventy-seven (51.6%)samples found to be contaminated with aflatoxin B1 levels higher than permissible level of European Commission (<20ng/g). For zearalenone, forty-four (32.5%) samples were tainted with levels ranging from ≥500 to 3750ng/gi.e. higher than recommendations by European commission (<500ng/g). In contrast to compound feed, mycotoxin analysis in silage samples demonstrated the high prevalence of ochratoxin A (77.8 %) followed by AFB1 (25%) with mean of 53 and 8.71ng/g respectively. A scrutiny of mycotoxin for total mixed ration depicted that all samples were contaminated with aflatoxin B1 and ochratoxin A with an average of 30 and 48.5ng/g respectively. As far as multi-mycotoxin co-existence is concerned, compound feed was concurrently contaminated with two, three and four types of mycotoxins

Entanglement transfer between bipartite systems

The problem of a controlled transfer of an entanglement initially encoded into two two-level atoms that are successively sent through two single-mode cavities is investigated. The atoms and the cavity modes form a four qubit system and we demonstrate under which conditions the initial entanglement encoded into the atoms can be completely transferred to other pairs of qubits. We find that in the case of a nonzero detuning between the atomic transition frequencies and the cavity mode frequencies, no complete transfer of the initial entanglement is possible to any of the other pairs of qubits. In the case of exact resonance and equal coupling strengths of the atoms to the cavity modes, an initial maximally entangled state of the atoms can be completely transferred to the cavity modes. The complete transfer of the entanglement is restricted to the cavity modes only with the transfer to the other pairs being limited to up to 50%. We have found that the complete transfer of an initial entanglement to other pairs of qubits may take place if the initial state is not the maximally entangled state and the atoms couple to the cavity modes with unequal strengths. Depending on the ratio between the coupling strengths, the optimal entanglement can be created between the atoms and one of the cavity modes.Comment: 3 figures. Oral talk presented in CEWQO 18, Madrid 201

In-situ growth of nonstoichiometric CrO0.87 and Co3O4 hybrid system for the enhanced electrocatalytic water splitting in alkaline media

The development of electrocatalysts for electrochemical water splitting has received considerable attention in response to the growing demand for renewable energy sources and environmental concerns. In this study, a simple hydrothermal growth approach was developed for the in-situ growth of non-stoichiometric CrO0.87 and Co3O4 hybrid materials. It is apparent that the morphology of the prepared material shows a heterogeneous aggregate of irregularly shaped nanoparticles. Both CrO0.87 and Co3O4 have cubic crystal structures. Its chemical composition was governed by the presence of Co, Cr, and O as its main constituents. For understanding the role CrO0.87 plays in the half-cell oxygen evolution reaction (OER) in alkaline conditions, CrO0.87 was optimized into Co3O4 nanostructures. The hybrid material with the highest concentration of CrO0.87 was found to be highly efficient at driving OER reactions at 255 mV and 20 mA cm−2. The optimized material demonstrated excellent durability for 45 h and a Tafel slope of 56 mV dec−1. Several factors may explain the outstanding performance of CrO0.87 and Co3O4 hybrid materials, including multiple metallic oxidation states, tailored surface properties, fast charge transport, and surface defects. An alternative method is proposed for the preparation of new generations of electrocatalysts for the conversion and storage of energy

Structure Preserving Splitting Techniques for Ebola Reaction–Diffusion Epidemic System

In this paper, we deal with the numerical solution of the reaction–diffusion Ebola epidemic model. The diffusion which is an important phenomenon for the epidemic model is included in the model. This inclusion has made the model more comprehensive for studying the disease dynamics in the human population. The quantities linked with the model indicate the population sizes which are taken as absolute, therefore, the numerical schemes utilized to solve the underlying Ebola epidemic system should sustain the positivity. The numerical approaches used to solve the underlying epidemic models are explicit nonstandard finite difference operator splitting (ENSFD-OS) and implicit nonstandard finite difference operator splitting (INSFD-OS) techniques. These schemes preserve all the physical features of the state variables, i.e. projected schemes hold the positive solution acquired by the Ebola diffusive epidemic model. The underlying epidemic model illustrates two stable steady states, a virus-free state, and a virus existence state. The suggested approaches retain the stability of each of the steady states possessed by the assumed epidemic model. A numerical example and simulations for validation of all the characteristics of suggested techniques are also investigated

A successful chronic care program in Al Ain-United Arab Emirates

<p>Abstract</p> <p>Background</p> <p>The cost effective provision of quality care for chronic diseases is a major challenge for health care systems. We describe a project to improve the care of patients with the highly prevalent disorders of diabetes and hypertension, conducted in one of the major cities of the United Arab Emirates.</p> <p>Settings and Methods</p> <p>The project, using the principles of quality assurance cycles, was conducted in 4 stages.</p> <p>The assessment stage consisted of a community survey and an audit of the health care system, with particular emphasis on chronic disease care. The information gleaned from this stage provided feedback to the staff of participating health centers. In the second stage, deficiencies in health care were identified and interventions were developed for improvements, including topics for continuing professional development.</p> <p>In the third stage, these strategies were piloted in a single health centre for one year and the outcomes evaluated. In the still ongoing fourth stage, the project was rolled out to all the health centers in the area, with continuing evaluation. The intervention consisted of changes to establish a structured care model based on the predicted needs of this group of patients utilizing dedicated chronic disease clinics inside the existing primary health care system. These clinics incorporated decision-making tools, including evidence-based guidelines, patient education and ongoing professional education.</p> <p>Results</p> <p>The intervention was successfully implemented in all the health centers. The health care quality indicators that showed the greatest improvement were the documentation of patient history (e.g. smoking status and physical activity); improvement in recording physical signs (e.g. body mass index (BMI)); and an improvement in the requesting of appropriate investigations, such as HbA1c and microalbuminurea. There was also improvement in those parameters reflecting outcomes of care, which included HbA1c, blood pressure and lipid profiles. Indicators related to lifestyle changes, such as smoking cessation and BMI, failed to improve.</p> <p>Conclusion</p> <p>Chronic disease care is a joint commitment by health care providers and patients. This combined approach proved successful in most areas of the project, but the area of patient self management requires further improvement.</p

A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese

Systemic lupus erythematosus (SLE) is an autoimmune disease that causes multiple organ damage. Although recent genome-wide association studies (GWAS) have contributed to discovery of SLE susceptibility genes, few studies has been performed in Asian populations. Here, we report a GWAS for SLE examining 891 SLE cases and 3,384 controls and multi-stage replication studies examining 1,387 SLE cases and 28,564 controls in Japanese subjects. Considering that expression quantitative trait loci (eQTLs) have been implicated in genetic risks for autoimmune diseases, we integrated an eQTL study into the results of the GWAS. We observed enrichments of cis-eQTL positive loci among the known SLE susceptibility loci (30.8%) compared to the genome-wide SNPs (6.9%). In addition, we identified a novel association of a variant in the AF4/FMR2 family, member 1 (AFF1) gene at 4q21 with SLE susceptibility (rs340630; P = 8.3×10−9, odds ratio = 1.21). The risk A allele of rs340630 demonstrated a cis-eQTL effect on the AFF1 transcript with enhanced expression levels (P<0.05). As AFF1 transcripts were prominently expressed in CD4+ and CD19+ peripheral blood lymphocytes, up-regulation of AFF1 may cause the abnormality in these lymphocytes, leading to disease onset

The non-coding transcriptome as a dynamic regulator of cancer metastasis.

Since the discovery of microRNAs, non-coding RNAs (NC-RNAs) have increasingly attracted the attention of cancer investigators. Two classes of NC-RNAs are emerging as putative metastasis-related genes: long non-coding RNAs (lncRNAs) and small nucleolar RNAs (snoRNAs). LncRNAs orchestrate metastatic progression through several mechanisms, including the interaction with epigenetic effectors, splicing control and generation of microRNA-like molecules. In contrast, snoRNAs have been long considered "housekeeping" genes with no relevant function in cancer. However, recent evidence challenges this assumption, indicating that some snoRNAs are deregulated in cancer cells and may play a specific role in metastasis. Interestingly, snoRNAs and lncRNAs share several mechanisms of action, and might synergize with protein-coding genes to generate a specific cellular phenotype. This evidence suggests that the current paradigm of metastatic progression is incomplete. We propose that NC-RNAs are organized in complex interactive networks which orchestrate cellular phenotypic plasticity. Since plasticity is critical for cancer cell metastasis, we suggest that a molecular interactome composed by both NC-RNAs and proteins orchestrates cancer metastasis. Interestingly, expression of lncRNAs and snoRNAs can be detected in biological fluids, making them potentially useful biomarkers. NC-RNA expression profiles in human neoplasms have been associated with patients' prognosis. SnoRNA and lncRNA silencing in pre-clinical models leads to cancer cell death and/or metastasis prevention, suggesting they can be investigated as novel therapeutic targets. Based on the literature to date, we critically discuss how the NC-RNA interactome can be explored and manipulated to generate more effective diagnostic, prognostic, and therapeutic strategies for metastatic neoplasms

Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Background Osteoarthritis is the most common form of arthritis in adults, characterised by chronic pain and loss of mobility. Osteoarthritis most frequently occurs after age 40 years and prevalence increases steeply with age. WHO has designated 2021–30 the decade of healthy ageing, which highlights the need to address diseases such as osteoarthritis, which strongly affect functional ability and quality of life. Osteoarthritis can coexist with, and negatively effect, other chronic conditions. Here we estimate the burden of hand, hip, knee, and other sites of osteoarthritis across geographies, age, sex, and time, with forecasts of prevalence to 2050. Methods In this systematic analysis for the Global Burden of Disease Study, osteoarthritis prevalence in 204 countries and territories from 1990 to 2020 was estimated using data from population-based surveys from 26 countries for knee osteoarthritis, 23 countries for hip osteoarthritis, 42 countries for hand osteoarthritis, and US insurance claims for all of the osteoarthritis sites, including the other types of osteoarthritis category. The reference case definition was symptomatic, radiographically confirmed osteoarthritis. Studies using alternative definitions from the reference case definition (for example self-reported osteoarthritis) were adjusted to reference using regression models. Osteoarthritis severity distribution was obtained from a pooled meta-analysis of sources using the Western Ontario and McMaster Universities Arthritis Index. Final prevalence estimates were multiplied by disability weights to calculate years lived with disability (YLDs). Prevalence was forecast to 2050 using a mixed-effects model. Findings Globally, 595 million (95% uncertainty interval 535–656) people had osteoarthritis in 2020, equal to 7·6% (95% UI 6·8–8·4) of the global population, and an increase of 132·2% (130·3–134·1) in total cases since 1990. Compared with 2020, cases of osteoarthritis are projected to increase 74·9% (59·4–89·9) for knee, 48·6% (35·9–67·1) for hand, 78·6% (57·7–105·3) for hip, and 95·1% (68·1–135·0) for other types of osteoarthritis by 2050. The global age-standardised rate of YLDs for total osteoarthritis was 255·0 YLDs (119·7–557·2) per 100 000 in 2020, a 9·5% (8·6–10·1) increase from 1990 (233·0 YLDs per 100 000, 109·3–510·8). For adults aged 70 years and older, osteoarthritis was the seventh ranked cause of YLDs. Age-standardised prevalence in 2020 was more than 5·5% in all world regions, ranging from 5677·4 (5029·8–6318·1) per 100 000 in southeast Asia to 8632·7 (7852·0–9469·1) per 100 000 in high-income Asia Pacific. Knee was the most common site for osteoarthritis. High BMI contributed to 20·4% (95% UI –1·7 to 36·6) of osteoarthritis. Potentially modifiable risk factors for osteoarthritis such as recreational injury prevention and occupational hazards have not yet been explored in GBD modelling. Interpretation Age-standardised YLDs attributable to osteoarthritis are continuing to rise and will lead to substantial increases in case numbers because of population growth and ageing, and because there is no effective cure for osteoarthritis. The demand on health systems for care of patients with osteoarthritis, including joint replacements, which are highly effective for late stage osteoarthritis in hips and knees, will rise in all regions, but might be out of reach and lead to further health inequity for individuals and countries unable to afford them. Much more can and should be done to prevent people getting to that late stage

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. Findings In 2019, there were 12·2 million (95% UI 11·0–13·6) incident cases of stroke, 101 million (93·2–111) prevalent cases of stroke, 143 million (133–153) DALYs due to stroke, and 6·55 million (6·00–7·02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11·6% [10·8–12·2] of total deaths) and the third-leading cause of death and disability combined (5·7% [5·1–6·2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70·0% (67·0–73·0), prevalent strokes increased by 85·0% (83·0–88·0), deaths from stroke increased by 43·0% (31·0–55·0), and DALYs due to stroke increased by 32·0% (22·0–42·0). During the same period, age-standardised rates of stroke incidence decreased by 17·0% (15·0–18·0), mortality decreased by 36·0% (31·0–42·0), prevalence decreased by 6·0% (5·0–7·0), and DALYs decreased by 36·0% (31·0–42·0). However, among people younger than 70 years, prevalence rates increased by 22·0% (21·0–24·0) and incidence rates increased by 15·0% (12·0–18·0). In 2019, the age-standardised stroke-related mortality rate was 3·6 (3·5–3·8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3·7 (3·5–3·9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62·4% of all incident strokes in 2019 (7·63 million [6·57–8·96]), while intracerebral haemorrhage constituted 27·9% (3·41 million [2·97–3·91]) and subarachnoid haemorrhage constituted 9·7% (1·18 million [1·01–1·39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79·6 million [67·7–90·8] DALYs or 55·5% [48·2–62·0] of total stroke DALYs), high body-mass index (34·9 million [22·3–48·6] DALYs or 24·3% [15·7–33·2]), high fasting plasma glucose (28·9 million [19·8–41·5] DALYs or 20·2% [13·8–29·1]), ambient particulate matter pollution (28·7 million [23·4–33·4] DALYs or 20·1% [16·6–23·0]), and smoking (25·3 million [22·6–28·2] DALYs or 17·6% [16·4–19·0]). Interpretation The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries.publishedVersio